SCHEMBL8188705

SCHEMBL8188705

O=C1NC(=O)C(=CC=Cc2ccc(O)cc2)S1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 3/20 0.68
▸ HPGD P15428 3/20 0.68
▸ AKR1B1 P15121 2/20 0.68
▸ GSK3B P49841 1/20 0.68
▸ RAB9A P51151 1/20 0.68
▸ PNP P00491 1/20 0.54
▸ CDC25B P30305 1/20 0.53
▸ MRE11 P49959 1/20 0.53
▸ NAT1 P18440 1/20 0.53
▸ POLB P06746 2/20 0.50
▸ MAPT P10636 2/20 0.50
▸ RECQL P46063 2/20 0.50
▸ L3MBTL1 Q9Y468 2/20 0.50
▸ KDM4E B2RXH2 1/20 0.50
▸ NSD2 O96028 1/20 0.50
▸ GAA P10253 1/20 0.50
▸ MAPK1 P28482 1/20 0.50
▸ GFER P55789 1/20 0.50
▸ MCL1 Q07820 1/20 0.50
▸ PIK3CA P42336 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22409611 0.85 PIM1 (0.67) HPGDAKR1B1GSK3BRAB9ACDC25B
SCHEMBL22423780 0.85 PIM1 (0.67) HPGDAKR1B1GSK3BRAB9ACDC25B
SCHEMBL13846678 0.85 PIM1 (0.67) HPGDAKR1B1GSK3BRAB9ACDC25B
SCHEMBL8172756 0.81 PIM1 (0.57) HPGDAKR1B1GSK3BCDC25BNAT1
SCHEMBL12892017 0.81 PIM1 (0.72) TDP1HPGDGSK3BRAB9AMAPT
SCHEMBL1249305 0.81 PIM1 (0.72) TDP1HPGDGSK3BRAB9AMAPT
SCHEMBL621991 0.81 TDP1 (1.00) TDP1HPGDAKR1B1GSK3BRAB9A
SCHEMBL621990 0.81 TDP1 (1.00) TDP1HPGDAKR1B1GSK3BRAB9A
SCHEMBL621989 0.81 TDP1 (1.00) TDP1HPGDAKR1B1GSK3BRAB9A
SCHEMBL14381413 0.81 PIM1 (0.55) TDP1HPGDAKR1B1GSK3BRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000018746-A1 THIAZOLIDINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF METABOLIC BONE DISORDERS ROCHE DIAGNOSTICS GMBH (DE) 2000-04-06 — — WO disclosed
Send feedback